Drug class

Agents to Treat Opioid (Opiate) Dependence

Agents to treat opioid dependence represent a functional and formulary drug classification used to manage opioid use disorder and support detoxification or long-term maintenance therapy. Read more about Agents to Treat Opioid (Opiate) Dependence

106 drugs in this class 60 manufacturers

Advertisement

Drugs in Agents to Treat Opioid (Opiate) Dependence

Showing 82–90 of 106 drugs

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1
SpecGx

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1
Avet Pharmaceuticals

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2
Hikma Pharmaceuticals USA

BUPRENORPHINE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · PREVENTION OF RELAPSE TO OPIOID DEPENDENCE ·+1
A-S MEDICATION

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2
LONG GROVE PHAR

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1
APHENA PHARMA S

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1
ELITE LABORATOR

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1
GSMS, INC.

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2
ELITE LABORATOR
Filter & compare in the drug finder → Opens the drug finder with Agents to Treat Opioid (Opiate) Dependence preselected. Add indication or manufacturer filters there.

About Agents to Treat Opioid (Opiate) Dependence.

Agents to treat opioid dependence represent a functional and formulary drug classification used to manage opioid use disorder and support detoxification or long-term maintenance therapy.

While the phrase serves as a clinical indication grouping rather than a single pharmacologic mechanism, its primary medications include full opioid receptor agonists, partial mu-opioid receptor agonists, and pure opioid receptor antagonists.

These pharmacotherapies function by stabilizing brain neurochemistry, mitigating debilitating withdrawal symptoms, suppressing drug cravings, or blocking the euphoric effects of exogenous opioids.

The class is predominantly indicated for the comprehensive medical management of moderate to severe opioid dependence and addiction, typically integrated with psychosocial and behavioral counseling.